Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$486,197
in 8 filings

Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-21 Blanks Robert Sale −4,855 $7.81 $38K 362,331
2024-05-14 RAAB MICHAEL President & CEO Sale 10b5-1 −3,000 $7.99 $24K 1,307,933
2024-05-06 Felsch Robert Ora Exercise or conversion +79,101 $0.84 $66K 263,935
2024-05-06 Felsch Robert Ora Exercise or conversion +40,000 $2.75 $110K 303,935
2024-05-06 Felsch Robert Ora Sale −152,988 $8.81 $1.3M 150,947
2024-05-06 Felsch Robert Ora Sale −55,000 $8.80 $484K 95,947
2024-05-06 Felsch Robert Ora Exercise or conversion · Stock Option (Right to Buy) −79,101 61,525
2024-05-06 Felsch Robert Ora Exercise or conversion · Stock Option (Right to Buy) −40,000 80,000
2024-05-06 GRAMMER ELIZABETH A Exercise or conversion +110,250 $0.99 $109K 378,243
2024-05-06 GRAMMER ELIZABETH A Exercise or conversion +109,687 $2.75 $302K 487,930
2024-05-06 GRAMMER ELIZABETH A Sale −64,233 $8.87 $570K 423,697
2024-05-06 GRAMMER ELIZABETH A Sale −219,937 $8.88 $2.0M 203,760
2024-05-06 GRAMMER ELIZABETH A Exercise or conversion · Stock Option (Right to Buy) −110,250 85,750
2024-05-06 GRAMMER ELIZABETH A Exercise or conversion · Stock Option (Right to Buy) −109,687 241,313
2024-05-03 GRAMMER ELIZABETH A Sale 10b5-1 −45,000 $9.00 $405K 267,993
2024-05-03 Williams Laura A Chief Medical Officer Exercise or conversion 10b5-1 +30,000 $0.99 $30K 410,138
2024-05-03 Williams Laura A Chief Medical Officer Sale 10b5-1 −39,949 $8.35 $334K 370,189
2024-05-03 Williams Laura A Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −30,000 162,000
2024-04-29 RAAB MICHAEL President & CEO Exercise or conversion 10b5-1 +30,000 $0.99 $30K 1,340,933
2024-04-29 RAAB MICHAEL President & CEO Sale 10b5-1 −30,000 $6.40 $192K 1,310,933

Page 15 of 18 · 360 trades